Some of Wednesday's midday movers:» Read More
Investors will soon have earnings to add to their watch list, but unlike interest rates and energy prices they may yield a positive surprise. Though interest rates and subprime worries have rattled stocks lately, corporate profits will also be closely watched in the coming weeks. And many market pros think that--like the first quarter--the results will come in above unrealistically low forecasts.
Cramer’s breaking out his trusty Shakira Theorem to explain aristocrat stocks – those companies that have increased their dividends every year for the past 25 years. Owning these kinds of stocks is like being born into old money: they keep paying you more every year to do nothing. Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Saks, Acadia Pharma, Geron, Harley Davidson, Walgreen and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Walgreen, the nation's largest drugstore chain by revenue, on Monday said fiscal second-quarter net income rose nearly 25% as sales at established stores increased on the strength of a strong retail prescription business.
Week two is now in the books. So--what can contest players do to get the edge in the game this week? Friday night's hour long special on CNBC "How To Win," provided some interesting picks and strategies. We'll be posting some excerpts from the show througout today.
For the first Lightning Round of the Cramer's third year, he fires off advice on Disney, Ameriprise, Walgreen and more...
Former AOL boss Steve Case tells Maria Bartiromo about the big opportunities in helping consumers find a trusted name in a troubled field. Case has launched Revolution Health Group in a bid to redefine a business and is teaming up with some top retailers to do it. (More)
Rite Aid shareholders overwhelmingly approved a nearly $3 billion deal to buy more than 1,800 Brooks and Eckerd stores and become the largest drugstore operator on the East Coast.
Wayne Best tells CNBC's Michelle Caruso-Cabrera that card redemptions by "the cautious consumer" will boost sales volume in the week following Christmas.
Tokyo stocks closed almost flat on Christmas Day. Trade was thin, with participants citing the holidays in overseas markets.
Stocks bucked a trend and closed lower on the last session before the Christmas holiday on investor concerns about a slower economy.
The shareholders' motion filed Thursday evening claims that Caremark board members will personally benefit from the CVS deal and have entered into a strict merger agreement that keeps them from seeking out the best deal for shareholders.
Profit was $431.7 million, or 43 cents a share, in the fiscal first quarter ended Nov. 30, compared with $345.6 million, or 34 cents a share, a year earlier.
Freeman tells CNBC's Carl Quintanilla why consumer confidence will soften and housing inventories will improve in 2007 in an interview only on cnbc.com’s home page.
U.S. stocks staged a powerful rally as another string of deals boosted momentum and sent a number of indexes to new highs. Mary Thompson is CNBC’s Eye on the Floor at the NYSE and had all the final details with a look at the markets on "Closing Bell." Today’s flurry of mergers and acquisitions exceeded $20 billion dollars.
Walgreen posted a greater-than-expected 9.3% rise in sales at stores open at least a year in November, sending its shares up more than 3%.